SPIRIT-HF missed its primary composite endpoint at 2 years, with higher observed event rates on spironolactone versus placebo ...

Sotatercept significantly reduces pulmonary vascular resistance in patients with CpcPH–HFpEF compared with placebo, according to a trial.

Starting a statin may improve outcomes in patients with heart failure with preserved ejection fraction (HFpEF) who are initially free from atherosclerotic cardiovascular disease (ASCVD), according to ...

"Atrial fibrillation and heart failure are growing epidemics, and both beget each other." ---- Jonathan Hsu, MD, MAS, University of California San Diego “Atrial fibrillation and heart failure are ...

A new study from Temple University and Cedars-Sinai has revealed that mitochondrial remodeling and metabolic disruptions are key contributors to heart failure with preserved ejection fraction (HFpEF).

Subclinical heart failure with preserved ejection fraction (HFpEF) was found in about three out of every four patients undergoing catheter ablation for symptomatic atrial fibrillation (AF) in a single ...

The Company is seeking approval of tirzepatide for the treatment of HFpEF and obesity and has submitted data to the FDA. Detailed results were announced from a phase 3 clinical trial evaluating the ...

A new study suggests severe obesity may weaken heart muscle cells in people with heart failure with preserved ejection ...

Please provide your email address to receive an email when new articles are posted on . Compared with just a few years ago, medical treatment options for HF with preserved ejection fraction have ...

HFpEF in hypertrophic cardiomyopathy predicts adverse outcomes. Discover how machine learning improves risk assessment.

In a new research report, a team of scientists led by Johns Hopkins Medicine say people with severe obesity and a common type ...